SCHEMBL12818772

SCHEMBL12818772

Cc1nc2ccc(S(=O)(=O)N3CCSc4ccc(-c5c(C)noc5C)cc43)cc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 7/20 0.45
▸ KDM2B Q8NHM5 1/20 0.42
▸ PKM P14618 2/20 0.42
▸ PKLR P30613 1/20 0.42
▸ BRD2 P25440 6/20 0.40
▸ BRD3 Q15059 6/20 0.40
▸ LMNA P02545 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ DRD2 P14416 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ LIPG Q9Y5X9 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CPT2 P23786 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12817923 0.85 LMNA (0.47) KDM2BPKMPKLRLMNAALDH1A1
SCHEMBL12818708 0.84 BRD4 (0.45) BRD4KDM2BPKMPKLRBRD2
SCHEMBL12818367 0.83 PKM (0.45) KDM2BPKMPKLRLMNAALDH1A1
SCHEMBL12817768 0.83 BRD4 (0.40) BRD4BRD2BRD3LMNAALDH1A1
SCHEMBL12818308 0.82 PKM (0.43) KDM2BPKMPKLRLMNAALDH1A1
SCHEMBL12818524 0.82 PKM (0.44) KDM2BPKMPKLRLMNAALDH1A1
SCHEMBL12818150 0.82 PKM (0.44) KDM2BPKMPKLRLMNAALDH1A1
SCHEMBL12818462 0.82 PKM (0.46) KDM2BPKMPKLRLMNAALDH1A1
SCHEMBL12818495 0.82 PKM (0.44) KDM2BPKMPKLRLMNAALDH1A1
SCHEMBL12817919 0.82 BRD4 (0.41) BRD4KDM2BPKMPKLRBRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback